Comments
Loading...

Cyclerion Therapeutics

CYCNNASDAQ
Logo brought to you by Benzinga Data
$1.43
0.010.70%
At close: -
$1.45
0.021.40%
After Hours: 9:29 AM EDT

Cyclerion Therapeutics (NASDAQ:CYCN) Stock Quotes, Forecast and News Summary

Cyclerion Therapeutics Stock (NASDAQ: CYCN) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Open$1.42
Close$1.43
Volume / Avg.79.65K / 221.71K
Day Range$1.27 - $1.55
52 Wk Range1.42 - 5.25
Market Cap$3.93M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest
0.78%
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CYCN
THAR

FAQ

Q

How do I buy Cyclerion Therapeutics (CYCN) stock?

A

You can purchase shares of Cyclerion Therapeutics (NASDAQ:CYCN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cyclerion Therapeutics (CYCN) competitors?

Q

What is the forecast, or price target, for Cyclerion Therapeutics (CYCN) stock?

A

There is no analysis for Cyclerion Therapeutics to provide a consensus price target.

Q

What is the current price for Cyclerion Therapeutics (CYCN)?

A

The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $1.45 last updated November 22, 2024 at 9:29 AM EST.

Q

Does Cyclerion Therapeutics (CYCN) pay a dividend?

A

There are no upcoming dividends for Cyclerion Therapeutics.

Q

When is Cyclerion Therapeutics (NASDAQ:CYCN) reporting earnings?

A

Cyclerion Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Q

Is Cyclerion Therapeutics (CYCN) going to split?

A

There is no upcoming split for Cyclerion Therapeutics.

Q

What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

A

Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch